Connect with us

CBD News

UK Customers Will Have Access to Clever Leaves ESENIA CBD Product Soon



UK Customers Will Have Access to Clever Leaves ESENIA CBD Product Soon

The United Kingdom has slowly evolved in their cannabis legalization, which has led many companies to keep the same pace in launching their new remedies in the country. Now, according to reports from UK-based news website Proactive, the co-founder and CEO of Clever Leaves decided to sit down for a chat ahead of their upcoming CBD product launch for ESENIA.

CEO Andrés Farjado told Proactive London’s Andrew Scott that this brand is one of the first players in the global cannabis industry to set its sights on the UK. ESENIA is designed to be a CBD brand for women, and it was announced at the Cannabis Europa conference in June, despite not launching until next week.

This range of products is designed to help women remain fit and healthy by reducing stress, increasing sleep quality, enhancing focus, and reducing pain. There are presently five products in the lineup, including ESSENTIAL. The CBD formula should be sprayed sublingually, taking about 15 seconds to get the desired effect for up to eight hours. Consumers that have not used a CBD remedy before can slowly increase the dosage as needed, but should start with one spray, working up to three times a day.

Continue Reading

Ultimate CBD Guide


ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email

Copyright © 2020 | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.